These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 26075451)

  • 21. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK; Garg P; Babu KH; Gopinathan U; Sharma S
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination drug testing of Mycobacterium chelonae.
    Matoba AY; Lee BL; Robinson NM; Penland R; Osato MS
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2786-9. PubMed ID: 8344799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium interface keratitis after laser in situ keratomileusis.
    Solomon A; Karp CL; Miller D; Dubovy SR; Huang AJ; Culbertson WW
    Ophthalmology; 2001 Dec; 108(12):2201-8. PubMed ID: 11733259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis.
    Giaconi J; Pham R; Ta CN
    J Cataract Refract Surg; 2002 May; 28(5):887-90. PubMed ID: 11978473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
    Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The increasing problem of antibiotic resistance.
    Mamalis N
    J Cataract Refract Surg; 2007 Nov; 33(11):1831-2. PubMed ID: 17964369
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
    Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
    Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nontuberculous mycobacterial keratitis in south Florida.
    Ford JG; Huang AJ; Pflugfelder SC; Alfonso EC; Forster RK; Miller D
    Ophthalmology; 1998 Sep; 105(9):1652-8. PubMed ID: 9754173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
    Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
    Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.
    Girgis DO; Karp CL; Miller D
    Clin Exp Ophthalmol; 2012 Jul; 40(5):467-75. PubMed ID: 21902780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
    Sarayba MA; Shamie N; Reiser BJ; Sweet PM; Taban M; Graff JM; Kesler-Diaz A; Osann KE; McDonnell PJ
    J Cataract Refract Surg; 2005 Jul; 31(7):1396-402. PubMed ID: 16105613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mycobacterium massiliense keratitis.
    Liu X; Zhao Y; Yang Y; Xu Y; Jiang Y; Dong F; Long Q
    Optom Vis Sci; 2012 Jun; 89(6):E944-7. PubMed ID: 22327797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
    Chang MH; Fung HB
    Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nontuberculous mycobacterial keratitis. Report of two cases and review of the literature.
    Bullington RH; Lanier JD; Font RL
    Arch Ophthalmol; 1992 Apr; 110(4):519-24. PubMed ID: 1562261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis.
    Daines BS; Vroman DT; Sandoval HP; Steed LL; Solomon KD
    J Cataract Refract Surg; 2003 May; 29(5):1014-8. PubMed ID: 12781292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
    Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
    Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy.
    de la Cruz J; Behlau I; Pineda R
    J Cataract Refract Surg; 2007 Jul; 33(7):1318-21. PubMed ID: 17586393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral Mycobacterium chelonae keratitis following LASIK.
    Verma S; Watson SL; Dart JK; Eykyn SJ
    J Refract Surg; 2003; 19(3):379-80. PubMed ID: 12777038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.